Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 414.21B | 412.94B | 402.77B | 389.87B | 366.23B | 355.35B |
Gross Profit | 188.57B | 188.78B | 180.60B | 174.61B | 179.10B | 179.87B |
EBITDA | 50.29B | 49.55B | 43.42B | 42.40B | 46.06B | 48.60B |
Net Income | 21.67B | 21.20B | 14.62B | 21.94B | 23.76B | 29.87B |
Balance Sheet | ||||||
Total Assets | 463.49B | 497.17B | 486.36B | 469.28B | 428.02B | 435.50B |
Cash, Cash Equivalents and Short-Term Investments | 80.83B | 102.24B | 85.53B | 109.06B | 103.91B | 130.13B |
Total Debt | 29.46B | 29.74B | 30.34B | 32.17B | 8.37B | 8.12B |
Total Liabilities | 152.87B | 181.47B | 188.23B | 190.11B | 163.01B | 190.65B |
Stockholders Equity | 289.04B | 293.72B | 280.32B | 264.25B | 251.57B | 231.72B |
Cash Flow | ||||||
Free Cash Flow | 20.09B | 25.60B | 5.08B | 18.82B | -23.63B | 13.80B |
Operating Cash Flow | 38.63B | 43.66B | 30.07B | 41.96B | 19.30B | 40.73B |
Investing Cash Flow | -7.82B | -7.66B | -34.79B | -19.54B | -34.18B | -19.87B |
Financing Cash Flow | -11.44B | -21.20B | -11.76B | -19.82B | -10.22B | -9.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥144.48B | 18.03 | 5.32% | 1.51% | 5.48% | ||
72 Outperform | $78.87B | 17.94 | 9.60% | 3.87% | 7.44% | 25.31% | |
68 Neutral | ¥196.73B | 21.07 | 8.29% | 2.38% | 5.00% | 2.96% | |
66 Neutral | $287.71B | 38.52 | 4.49% | 4.77% | -0.74% | -25.66% | |
65 Neutral | $472.33B | 14.95 | 12.05% | 1.97% | 13.95% | 0.37% | |
60 Neutral | $400.26B | 37.98 | 5.17% | 2.15% | -8.36% | -38.35% | |
59 Neutral | ¥408.46B | 19.19 | 7.58% | 1.86% | 2.30% | 33.87% |
Lion Corporation announced the disposal of 274,100 shares of treasury stock through a stock-based compensation plan aimed at aligning executive compensation with company performance and share price. This move is part of Lion’s ongoing strategy to incentivize its directors and executive officers, with the disposal expected to have an insignificant impact on the trading market due to the reasonable number of shares involved and the lack of immediate influx into the stock market.
Lion Corporation reported a modest increase in net sales for the first quarter of 2025, with a 1.4% rise compared to the previous year. The company saw significant growth in operating profit, up 15.2%, and profit before tax, which increased by 8.7%. Despite a decrease in total comprehensive income, core operating income showed a substantial improvement of 32.4% year-on-year, indicating strong underlying business performance. The company also announced a forecasted increase in dividends per share for fiscal 2025, reflecting confidence in its financial stability and commitment to shareholder returns.
Lion Corporation has announced its decision to cancel 4,650,000 shares of its treasury stock, which constitutes 1.63% of its outstanding shares, as part of a strategy to enhance shareholder value by increasing earnings per share. This move is expected to positively impact the company’s financial metrics and strengthen its market position by optimizing its capital structure.
Lion Corporation announced its decision to acquire all shares of its Vietnam-based affiliate, Merap Lion Holding Corporation, making it a wholly owned subsidiary. This acquisition is part of Lion’s Vision2030 2nd STAGE plan to strengthen its business portfolio and enhance growth overseas. By fully integrating Merap Lion, Lion aims to leverage synergies in product development and production technology, particularly in the oral healthcare sector, to boost its market presence in Vietnam and improve consolidated performance.